How to buy Imara stock (IMRA)

Imara is a biotechnology business based in the US. Imara shares (IMRA) are listed on the NASDAQ and all prices are listed in US Dollars. Imara employs 6 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy Imara stock

Buy Imara stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Imara stock price (NASDAQ: IMRA)

Use our graph to track the performance of IMRA stocks over time.

Imara shares at a glance

• Key figures

Information last updated 2024-01-24.

52-week range	$0.00 - $0.00
50-day moving average more info button	$4.55
200-day moving average more info button	$2.85
Wall St. target price	$1.40
PE ratio more info button	105.3333
Dividend yield more info button	$0 (0%)
Earnings per share (TTM) more info button	$0.06

Is it a good time to buy Imara stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Imara stock undervalued or overvalued?

Valuing Imara stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Imara's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Imara's P/E ratio

Imara's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 105x. In other words, Imara shares trade at around 105x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Imara financials

Gross profit TTM	$0
Return on assets TTM	-23.08%
Return on equity TTM	1.69%
Profit margin	0%
Book value	$3.43
Market Capitalization more info button	$165.8 million

TTM: trailing 12 months

Imara share dividends

We're not expecting Imara to pay a dividend over the next 12 months.

Have Imara's shares ever split?

Imara's shares were split on a 1:4 basis on 23 February 2023 . So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Imara shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for Imara shares which in turn could have impacted Imara's share price.

Imara share price volatility

Over the last 12 months, Imara's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Imara's is 1.0813. This would suggest that Imara's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Imara overview

IMARA Inc. , a biopharmaceutical company, focuses on developing and commercializing novel therapeutics to treat patients suffering from serious diseases. The company was incorporated in 2016 and is based in Brookline, Massachusetts. .

Frequently asked questions

null
What percentage of Imara is owned by insiders or institutions?
Currently 16.632% of Imara shares are held by insiders and 81.321% by institutions. How many people work for Imara?
Latest data suggests 6 work at Imara. When does the fiscal year end for Imara?
Imara's fiscal year ends in December. Where is Imara based?
Imara's address is: 116 Huntington Avenue, Boston, MA, United States, 02116 What is Imara's ISIN number?
Imara's international securities identification number is: US45249V1070 What is Imara's CUSIP number?
Imara's Committee on Uniform Securities Identification Procedures number is: 45249V107